Changes in M&A deal capacities of the global pharmaceutical market from 2008 to 2015, by segment*

M&A capacities - changes for the global pharma industry 2008-2015 This statistic displays the changes in M&A deal capacities of the global pharmaceutical market from 2008 to 2014, broken down by segment. In 2012, with some 23 percent, the big biotech segment had the highest growth among all pharmaceutical segments.
Show more
Loading statistic...
Big biotechSpeciality pharmaBig pharma
200811%-35%-21%
20095%67%1%
20107%-5%-7%
20119%-11%10%
201223%2%3%
201355%63%19%
201430%42%12%
20153%-47%-6%
Big biotechSpeciality pharmaBig pharma
200811%-35%-21%
20095%67%1%
20107%-5%-7%
20119%-11%10%
201223%2%3%
201355%63%19%
201430%42%12%
20153%-47%-6%
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays the changes in M&A deal capacities of the global pharmaceutical market from 2008 to 2014, broken down by segment. In 2012, with some 23 percent, the big biotech segment had the highest growth among all pharmaceutical segments.
Show more
Release date
January 2016
Region
Worldwide
Survey time period
2008 to 2015
Age group
Supplementary notes
* The EY Firepower Index measures companies’ capacity for conducting M&A deals. A company’s firepower is diminished as its market value, cash and equivalents fall or as its debt levels rise.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical brands: Enbrel (Amgen/Pfizer)"

  • Overview
  • Drug prices and consumer behavior
The most important statistics
  • Advertising expenditures
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News